Become a Provider

Offer EarlyCDT-Lung to your Patients

Risk Assessment

Assess lung cancer risk

Find a Test Provider

See where you
can take the test

Publications &
Press

Case Studies & Testimonials
early-lung-cancer-detection
85% of lung cancers are diagnosed late stage | EarlyCDT-Lung

85% of lung cancers are diagnosed late stage

Find lung cancer before symptoms appear. EarlyCDT-Lung combined with CT can help.

Learn More
Autoantibodies are detectible up to 5 years before a tumor is visible.

EarlyCDT-Lung:

Panel of autoantibodies to aid in early lung cancer detection

Learn More

When Found Early Stage, 5 Year Survival Rate More Than Triples

Recent NLST Trial further shows 20% mortality improvement. EarlyCDT-Lung can reduce false positives associated with CT.

Learn More

EarlyCDT-Lung is a simple blood test that:

  • Has 7 times better Positive Predictive Value (PPV) than CT
  • Has 7 times fewer false positives than CT
  • Detects all types and all stages of lung cancer, including at the earliest stages
  • Positive test implies 7x risk of cancer
Learn More
Are you a medical professional? Learn More Are you a Test Provider? Learn More Are you a Patient? Learn More Become a provider and detect lung cancer at its earliest stage Learn More

Doctors

Your Challenge with Lung Cancer

How to identify the relatively small percentage of lung cancers (5-50 depending on the level of risk), per 1,000, that are present in your high-risk patient population. More….

Use of EarlyCDT-Lung:

  • As a risk assessment test to aid in the early detection of lung cancer in your high-risk patients; most notably long-term smokers and ex-smokers.
  • A new tool to risk stratify pulmonary nodules.

Patients

Brief Overview

EarlyCDT-Lung is a simple blood test which is ordered by a GP, or other suitably qualified medical professional, to aid in the risk assessment and early detection of lung cancer. More…

Risk Assessment:
Subscribe by Email
Your email: